{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T05:09:29Z","timestamp":1779167369624,"version":"3.51.4"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004586","name":"Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ijbiomac.2026.150985","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T16:21:36Z","timestamp":1771604496000},"page":"150985","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Trypanosoma cruzi carbonic anhydrase inhibitors as a potential antiparasitic agent"],"prefix":"10.1016","volume":"351","author":[{"given":"Sarah da Costa","family":"Lanera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo da Silva","family":"Lara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorraine Martins Rocha","family":"Orlando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thamyris Perez","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edinaldo Castro","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitoria Barbosa","family":"Paes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalia da Silva","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Giovannuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Nikitjuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessio","family":"Nocentini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Yves","family":"Winum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ver\u00f4nica da Silva","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edilma Paraguai de Souza","family":"Dias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alane Beatriz","family":"Vermelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirian Claudia de Souza","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2026.150985_bb0005","series-title":"Neglected Tropical Diseases","author":"World Health Organization","year":"2025"},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0010","series-title":"Ending the Neglect to Attain the Sustainable Development Goals: A Road Map for Neglected Tropical Diseases 2021\u20132030","author":"World Health Organization","year":"2020"},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0015","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-031-14619-0","article-title":"Incid\u00eancia da doen\u00e7a de Chagas aguda no estado do Par\u00e1-Brasil, entre os anos de 2010 e 2020","volume":"11","author":"Ferreira","year":"2022","journal-title":"Res. Soc. Dev."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2024.107264","article-title":"Tackling the challenges of human Chagas disease: a comprehensive review of treatment strategies in the chronic phase and emerging therapeutic approaches","volume":"256","author":"Ramos","year":"2024","journal-title":"Acta Trop."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0025","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01787-7","article-title":"Chagas disease","volume":"403","author":"de Sousa","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2019.100507","article-title":"Chagas disease: chronic Chagas cardiomyopathy","volume":"46","author":"Echavarria","year":"2021","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0035","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.3390\/jcm13092565","article-title":"Chagas disease: comparison of therapy with nifurtimox and benznidazole in indigenous communities in Colombia","volume":"13","author":"Kann","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0040","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.4269\/ajtmh.16-0761","article-title":"Experimental and clinical treatment of Chagas disease: a review","volume":"97","author":"Sales Junior","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0045","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(17)31612-4","article-title":"Chagas disease","volume":"391","author":"Molina","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0050","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1056\/NEJMoa1507574","article-title":"Randomized trial of benznidazole for chronic Chagas\u2019 cardiomyopathy","volume":"373","author":"Morillo","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0055","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMoa1313122","article-title":"Randomized trial of posaconazole and benznidazole for chronic Chagas' disease","volume":"370","author":"Molina","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0060","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jacc.2016.12.023","article-title":"Benznidazole and posaconazole in eliminating parasites in asymptomatic T. cruzi carriers: the STOP-CHAGAS trial","volume":"69","author":"Morillo","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0065","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1473-3099(17)30538-8","article-title":"Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial","volume":"18","author":"Torrico","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0070","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1473-3099(23)00651-5","article-title":"Efficacy and safety of fexinidazole for treatment of chronic indeterminate Chagas disease (FEXI-12): a multicentre, randomised, double-blind, phase 2 trial","volume":"24","author":"Pinazo","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/scipharm92030040","article-title":"Identification of potential Trypanosoma cruzi trans-sialidase inhibitors by computational drug repositioning approaches","volume":"92","author":"Uc-Chuc","year":"2024","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2023.215608","article-title":"Biosynthesis of ergosterol as a relevant molecular target of metal-based antiparasitic and antifungal compounds","volume":"503","author":"Scalese","year":"2024","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0085","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.2174\/0929867322666150521091652","article-title":"Cruzipain: an update on its potential as a chemotherapy target against the human pathogen Trypanosoma cruzi","volume":"22","author":"Branquinha","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116577","article-title":"Examination of multiple Trypanosoma cruzi targets in a new drug discovery approach for Chagas disease","volume":"58","author":"Beltran-Hortelano","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0095","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1126\/science.adh0614","article-title":"Cyanotriazoles are selective topoisomerase II poisons that rapidly cure trypanosome infections","volume":"380","author":"Rao","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0100","first-page":"847","article-title":"Carbonic anhydrases: novel therapeutic applications","volume":"27","author":"Supuran","year":"2017","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/14756366.2019.1677638","article-title":"A structure-based approach towards the identification of novel antichagasic compounds: Trypanosoma cruzi carbonic anhydrase inhibitors","volume":"35","author":"Llanos","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0110","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1021\/jm4000616","article-title":"Cloning, characterization, and sulfonamide and thiol inhibition studies of an \u03b1-carbonic anhydrase from Trypanosoma cruzi, the causative agent of Chagas disease","volume":"56","author":"Pan","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0115","series-title":"Carbonic Anhydrases","first-page":"3","article-title":"Carbonic anhydrases: an overview","author":"Nocentini","year":"2019"},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202400626","article-title":"The carbonic anhydrase enzymes as new targets for the management of neglected tropical diseases","volume":"358","author":"Renzi","year":"2025","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0125","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.1021\/jm400418p","article-title":"A class of sulfonamides with strong inhibitory action against the \u03b1-carbonic anhydrase from Trypanosoma cruzi","volume":"56","author":"G\u00fczel-Akdemir","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0130","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/14756366.2017.1405264","article-title":"Nanoemulsions of sulfonamide carbonic anhydrase inhibitors strongly inhibit the growth of Trypanosoma cruzi","volume":"33","author":"Vermelho","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0135","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1021\/jm400902y","article-title":"Design, synthesis, and evaluation of hydroxamic acid derivatives as promising agents for the management of Chagas disease","volume":"57","author":"Rodrigues","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0140","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1016\/j.bmc.2015.03.068","article-title":"Synthesis of a new series of dithiocarbamates with effective human carbonic anhydrase inhibitory activity and antiglaucoma action","volume":"23","author":"Bozdag","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0145","doi-asserted-by":"crossref","first-page":"13143","DOI":"10.1021\/acs.jmedchem.2c00982","article-title":"Development of hydrogen sulfide-releasing carbonic anhydrases IX- and XII-selective inhibitors with enhanced antihyperalgesic action in a rat model of arthritis","volume":"65","author":"Bonardi","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0150","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1021\/acs.jmedchem.9b01669","article-title":"\u201cA sweet combination\u201d: developing saccharin and acesulfame K structures for selectively targeting the tumor-associated carbonic anhydrases IX and XII","volume":"63","author":"Bua","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0155","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3390\/ijms23010461","article-title":"Aromatic sulfonamides including a sulfonic acid tail: new membrane impermeant carbonic anhydrase inhibitors for targeting selectively the cancer-associated isoforms","volume":"23","author":"Giovannuzzi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0160","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.3390\/molecules27134076","article-title":"Continued structural exploration of sulfocoumarin as selective inhibitor of tumor-associated human carbonic anhydrases IX and XII","volume":"27","author":"Giovannuzzi","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0165","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2202360","article-title":"Discovery of the first-in-class potent and isoform-selective human carbonic anhydrase III inhibitors","volume":"38","author":"Giovannuzzi","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0170","doi-asserted-by":"crossref","first-page":"18221","DOI":"10.1021\/acs.jmedchem.4c01516","article-title":"Benzoxaborinine, new chemotype for carbonic anhydrase inhibition: ex novo synthesis, crystallography, in silico studies, and anti-melanoma cell line activity","volume":"67","author":"Giovannuzzi","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.109029","article-title":"Physiological modeling of the metaverse of the mycobacterium tuberculosis \u03b2-CA inhibition mechanism","volume":"181","author":"Giovannuzzi","year":"2024","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0180","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/chem.201805039","article-title":"Phosphorus versus sulfur: discovery of benzenephosphonamidates as versatile sulfonamide-mimic chemotypes acting as carbonic anhydrase inhibitors","volume":"25","author":"Nocentini","year":"2019","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0185","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0190","first-page":"198","article-title":"Interaction of Trypanosoma cruzi with heart muscle cells: ultrastructural and cytochemical analysis of endocytic vacuole formation and effect upon myogenesis in vitro","volume":"41","author":"Meirelles","year":"1986","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0195","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1086\/528373","article-title":"Fibrosis and hypertrophy induced by Trypanosoma cruzi in a three-dimensional cardiomyocyte-culture system","volume":"197","author":"Garzoni","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0200","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1756-3305-7-89","article-title":"In vivo imaging of mice infected with bioluminescent Trypanosoma cruzi unveils novel sites of infection","volume":"7","author":"Henriques","year":"2014","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0205","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.micinf.2018.03.002","article-title":"Trypanosoma cruzi infection of human induced pluripotent stem cell-derived cardiomyocytes: an in vitro model for drug screening for Chagas disease","volume":"20","author":"Lara","year":"2018","journal-title":"Microbes Infect."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0210","doi-asserted-by":"crossref","first-page":"995","DOI":"10.3390\/pharmaceutics14050995","article-title":"Bioactivity of novel pyrazole-thiazolines scaffolds against Trypanosoma cruzi: computational approaches and 3D spheroid model on drug discovery for Chagas disease","volume":"14","author":"Lara","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0215","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.3390\/molecules30153082","article-title":"Anti-Trypanosoma cruzi potential of new pyrazole-imidazoline derivatives","volume":"30","author":"de Oliveira","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0220","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ejmech.2017.12.052","article-title":"Efficacy of 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinone derivatives against different Trypanosoma cruzi discrete type units: identification of a promising hit compound","volume":"144","author":"Lara","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0225","doi-asserted-by":"crossref","first-page":"6742","DOI":"10.3390\/molecules26216742","article-title":"Structural optimization and biological activity of pyrazole derivatives: virtual computational analysis, recovery assay and 3D culture model as potential predictive tools of effectiveness against Trypanosoma cruzi","volume":"26","author":"Orlando","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0230","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1128\/AAC.48.11.4097-4102.2004","article-title":"Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum","volume":"48","author":"Fivelman","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0235","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/jac\/dkv495","article-title":"Efficacy of tamoxifen and miltefosine combined therapy for cutaneous leishmaniasis in the murine model of infection with Leishmania amazonensis","volume":"71","author":"Trinconi","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0240","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.3390\/biology12091222","article-title":"Antitrypanosomal activity of 1,2,3-triazole-based hybrids evaluated using in vitro preclinical translational models","volume":"12","author":"Orlando","year":"2023","journal-title":"Biology"},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0250","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2017.09.016","article-title":"Overcoming key biological barriers to cancer drug delivery and efficacy","volume":"267","author":"Kim","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0255","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1021\/acsinfecdis.0c00353","article-title":"Chagas disease: current view of an ancient and global chemotherapy challenge","volume":"6","author":"Mart\u00edn-Escolano","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0260","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1021\/acsmedchemlett.8b00430","article-title":"N-nitrosulfonamides as carbonic anhydrase inhibitors: a promising chemotype for targeting Chagas disease and leishmaniasis","volume":"10","author":"Bonardi","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0265","doi-asserted-by":"crossref","first-page":"964","DOI":"10.3109\/14756366.2015.1077330","article-title":"Hydroxamic acid derivatives: a promising scaffold for rational compound optimization in Chagas disease","volume":"31","author":"de Menezes","year":"2015","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e41317","article-title":"Bridging the gap: from petri dish to patient \u2013 advancements in translational drug discovery","volume":"11","author":"El-Tanani","year":"2025","journal-title":"Heliyon"},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0275","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.3390\/biomedicines12071410","article-title":"Exploring the dimensions of pre-clinical research: 3D cultures as an investigative model of cardiac fibrosis in Chagas disease","volume":"12","author":"Seydel","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0280","article-title":"Benznidazole modulates release of inflammatory mediators by cardiac spheroids infected with Trypanosoma cruzi","volume":"221","author":"Fiuza","year":"2021","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e30740","article-title":"A 3D organoid platform that supports liver-stage P. falciparum infection can be used to identify intrahepatic antimalarial drugs","volume":"10","author":"Rao","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0290","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29153544","article-title":"Synthesis and anti-Trypanosoma cruzi activity of new pyrazole-thiadiazole scaffolds","volume":"29","author":"de Souza","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0295","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.3390\/ph18101552","article-title":"Pyrazole-Imidazoline derivative prevents cardiac damage and mortality in acute Trypanosoma cruzi infection","volume":"18","author":"Orlando","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0300","article-title":"Drug screening and development cascade for Chagas disease: an update of in vitro and in vivo experimental models","volume":"119","author":"Soeiro","year":"2024","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0305","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijpddr.2016.08.003","article-title":"Assessing anti-T. cruzi candidates in vitro for sterile cidality","volume":"6","author":"Cal","year":"2016","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006612","article-title":"Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas\u2019 disease drug discovery","volume":"12","author":"MacLean","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0315","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.34039","article-title":"Spontaneous dormancy protects Trypanosoma cruzi during extended drug exposure","volume":"7","author":"S\u00e1nchez-Vald\u00e9z","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0320","article-title":"New drugs and promising drug combinations in the treatment of Chagas disease in Brazil: a systematic review and meta-analysis","volume":"55","author":"Freire","year":"2024","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0325","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.drudis.2016.05.015","article-title":"Drug combination therapy increases successful drug repositioning","volume":"21","author":"Sun","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009081","article-title":"Joining forces: leveraging novel combination therapies to combat infections with eukaryotic pathogens","volume":"16","author":"Ham","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0335","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1017\/S0031182022000142","article-title":"Could combination chemotherapy be more effective than monotherapy in the treatment of visceral leishmaniasis? A systematic review of preclinical evidence","volume":"149","author":"Bastos","year":"2022","journal-title":"Parasitol"},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0340","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00284-22","article-title":"Drug repurposing in Chagas disease: chloroquine potentiates benznidazole activity against Trypanosoma cruzi in vitro and in vivo","volume":"66","author":"Pandey","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijbiomac.2026.150985_bb0345","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2147\/JEP.S267378","article-title":"Review on experimental treatment strategies against Trypanosoma cruzi","volume":"13","author":"Mazzeti","year":"2021","journal-title":"J. Exp. Pharmacol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026009116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026009116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:22:42Z","timestamp":1779164562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026009116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":69,"alternative-id":["S0141813026009116"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.150985","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trypanosoma cruzi carbonic anhydrase inhibitors as a potential antiparasitic agent","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.150985","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150985"}}